Abstract: The present disclosure belongs to the technical field of plant pest control, and particularly relates to a Camellia sinensis endophyte Penicillium ehrlichii and an application thereof. The present disclosure relates to a novel endophyte separated from a Camellia sinensis body and identified as Penicillium ehrlichii by means of morphology and molecular biology. Biological activity evaluation indicates that Penicillium ehrlichii shows good antagonistic antifungal activity to common pathogenic fungi on several plants. It means that the strain used as a biocontrol fungus for phytopathogens can be applied to environmental-friendly and safe prevention and control of plant diseases.

Abstract: Disclosed are an attenuation system and the use thereof for attenuating plasmodia, specifically the use of an EF1g gene for attenuating plasmodia. The attenuation system regulates the expression or degradation of the EF1g gene by using a regulatory system, thereby controlling the growth of plasmodia and achieving the attenuation of plasmodia.

Abstract: An anti-neoplastic combined pharmaceutical composition and application thereof. The combined pharmaceutical composition is prepared from plasmodia and chemotherapeutic drugs. The combined pharmaceutical composition combines chemotherapy with Plasmodium immunotherapy, has high biosafety, has stronger antineoplastic activity than single chemotherapy or single Plasmodium immunotherapy, can prolong the lifetime of cancer patients, and provides a new strategy and idea for cancer treatment. Moreover, the dosage of the chemotherapy drugs can be reduced, toxic and side effects caused by the chemotherapy drugs are reduced, and treatment costs of tumor patients are reduced. In addition, the combined pharmaceutical composition can promote release of a tumor antigen, induces a stronger anti-tumor specific immune response, and exerts the continuous synergistic effect of immunotherapy and chemotherapy.

Abstract: An electrode catalyst for an oxygen reduction reaction including intermetallic L10-NiPtAg alloy nanoparticles having enhanced ORR activity and durability. The catalyst including intermetallic L10-NiPtAg alloy nanoparticles is synthesized by employing silver (Ag) as a dopant and annealing under specific conditions to form the intermetallic structure. In one example, the intermetallic L10-NiPtAg alloy nanoparticles are represented by the formula: NixPtyAgz wherein 0.4?x?0.6, 0.4?y?0.6, z?0.1.

Abstract: Disclosed are a combined formulation kit for analyzing the phenotype and function of a CD1c+ dendritic cell subset and the use thereof, wherein the detection objects of the kit include CD1c, CD40, IL-6 and IL-10. The kit can be used to efficiently and quickly identify the phenotype of a CD1c+ dendritic cell subset in peripheral blood and analyze the function thereof, thereby ensuring accuracy and reducing the economic cost produced by detecting a large number of surface antigen molecules, and the detection method is also simple to implement.

Abstract: Disclosed is a vehicle control method, including: obtaining a first velocity planned for an intelligent vehicle to travel in a first area; and obtaining a second velocity planned for the vehicle to travel in the first area, where the second velocity is obtained based on a collision potential energy, the first velocity and the second velocity each include a direction and a magnitude, and the first velocity, the second velocity, and a risk of a collision between the vehicle and a surrounding obstacle are used to determine an optimal velocity of the vehicle, so that the vehicle can effectively avoid the obstacle, thereby improving traveling safety of the vehicle. Also disclosed are a vehicle control apparatus, a vehicle controller, and a vehicle.

Abstract: One embodiment is directed to a non-contact, medical ultrasound therapy system for generating and controlling low frequency ultrasound. The ultrasound therapy system includes a treatment wand including an ultrasonic transducer, a generator unit, and a cable coupling the treatment wand to the generator unit. The generator unit generates electric power output to drive the ultrasonic transducer and includes a digital frequency generator, wherein the generator unit digitally controls energy output at resonance frequency of the ultrasonic transducer.

Abstract: Provided is a safety socket, including a first conductive seat, a second conductive seat, a first terminal, a first insulator, a second terminal, a second insulator, a first conductive sheet and a second conductive sheet. The first conductive seat includes a first elastic body. The first elastic body includes a first elastic connecting portion and two first elastic pieces. Both ends of the first elastic connecting portion are respectively integrally formed with the bottom ends of the first elastic pieces. The second conductive seat includes a second elastic body and a second socket terminal. The second elastic body includes a second elastic connecting portion and two second elastic pieces. Both ends of the second elastic connecting portion are respectively integrally formed with the bottom ends of the first elastic pieces. The elastic body can be reset by its own elastic force without a spring.

Abstract: A metal product includes a metal substrate, at least one first hole, at least one second hole, and at least one third hole. The first hole is formed in a surface of the metal substrate. The second hole is formed in at least one of a portion of the surface of the metal substrate without the first hole and an inner surface defining the first hole. The third hole is formed in at least one of a portion of the surface of the metal substrate without the first hole and without the second hole, a portion of the inner surface defining the first hole without the second hole, and an inner surface defining the second hole. The first, second, and third holes enhance a bonding strength between the metal product and a material product. The disclosure also provides a metal composite and a method for manufacturing the metal product.

Abstract: Implants comprising an antimalarial agent such as decoquinate or another therapeutic drug are disclosed. The implants can be in the form of a complex comprising a drug, a lipid or lipids and optionally a polymer carrier. The present invention provides methods for preparing implants wherein the implants comprise decoquinate or another therapeutic drug, and a lipid or lipids such as cholesterol, monoglycerides, or diglycerides, and optionally a small percentage of a biocompatible polymer based on the total implant weight. The implants are useful for releasing a therapeutic drug at a constant level and maintaining a prophylactic or therapeutic level of the drug in a subject, for preventing a malarial infection or treating other diseases or disorders.

Abstract: One embodiment is directed to a non-contact, medical ultrasound therapy system for generating and controlling low frequency ultrasound. The ultrasound therapy system includes a treatment wand including an ultrasonic transducer, a generator unit, and a cable coupling the treatment wand to the generator unit. The generator unit generates electric power output to drive the ultrasonic transducer and includes a digital frequency generator, wherein the generator unit digitally controls energy output at resonance frequency of the ultrasonic transducer.

Abstract: A method of Mura defect repair, the method including: decoding an image input signal into pixel grayscale data of a frame image; looking up a DeMura lookup table and DeMura control data, and performing linear interpolation on Mura designated areas of the frame image according to the DeMura lookup table and DeMura control data to obtain compensation data of the Mura designated areas of the frame image; and superposing the compensation data and the pixel grayscale data of the frame image to obtain a compensated frame image signal.

Abstract: A coated member, an electronic device, and a method for manufacturing the coated member are provided. The coated member comprises a substrate, a color layer formed on a surface of the substrate, and an interference layer formed on a surface of the color layer. A coordinate L* corresponding to a color space presented by the color layer in a CIE LAB color system is within a preset range. When the coordinates of L* are within the preset range, the color of the coated member may be the same or may be different from the color of the color layer. Light passes through the interference layer and then enters the color layer. The color layer reflects and refracts the light. The reflected light enters the interference layer. The interference layer interferes with the reflected light, so that the coated member appears to be a target color.

Abstract: An implantable device including a metal substrate; that contains particles having a size of 1 ?m or more; if the wall thickness of the metal substrate is greater than or equal to 0.04 mm and less than or equal to 0.12 mm, the largest particle size is less than or equal to 15 ?m and the average content of the particles is less than or equal to 40 ppm; if the wall thickness of the metal substrate is greater than 0.12 mm and less than or equal to 0.2 mm, the largest particle size is less than or equal to 20 ?m and the average content of the particles is less than or equal to 100 ppm; The size of the particles and the average content of the particles are reasonably controlled according to the wall thickness of the metal substrate, improving the plastic deformation capability of the implantable device.

Abstract: The present disclosure provides a cuboid magnetometer with high fluorescence collection efficiency, used for cardiac magnetic field measurement, and based on nitrogen-vacancy (NV) centers in diamond, and a cardiac magnetic field measurement system. The cardiac magnetic field measurement system includes a magnetic shielding chamber, a non-magnetic bed, an array probe for cardiac magnetic field measurement, a three-axis displacement platform, a high-speed data collection card, a fiber laser source, a microwave source, and a computer. The array probe for cardiac magnetic field measurement includes a non-magnetic shell, a stepping motor, a porous rotary fiber coupling apparatus, a fiber bundle set, a special photodetector (PD) set, a filter set, a ring-shaped antenna, and special diamond.

Abstract: An acoustic emission probe positioning system, a test block for the system, and an application of the system are disclosed. The positioning system comprises a first test block and a second test block that are oppositely arranged and that define a non-closed test region. The first test block includes a first main portion and a first protruding portion that are connected to each other. The second test block includes a second main portion and a second protruding portion that are connected to each other. The first main portion and the second main portion are vertically opposite to each other, and the first protruding portion and the second protruding portion are opposite to each other left and right in a staggered manner. Multiple first probe storage holes are defined in the first main portion, and multiple second probe storage holes are defined in the first protruding portion.

Abstract: An LED tube lamp comprises a glass tube, two end caps coupled to a respective end of the glass tube, an LED light strip attached to an inner circumferential surface of the glass tube, a protective layer disposed on a surface of the LED light strip, a plurality of LED light sources mounted on the LED light strip, two first soldering pads arranged at an end of the LED light strip, two notches formed at an edge of the end of the LED light strip, a power supply module configured to drive the plurality of LED light sources. The protective layer comprises two openings to expose the two first soldering pads. The power supply module comprises a printed circuit board comprising two second soldering pads and each of the two first soldering pad soldered to the respective second soldering pad by a solder. The solder is disposed on the first soldering pad, the corresponding second soldering pad and in the corresponding notch.

Abstract: Provided are a chimeric antigen receptor and an application thereof; said chimeric antigen receptor contains a domain which identifies any one of, or a combination of at least two of, the malarial protein VAR2CSA, a protein tag on malarial protein VAR2CSA, or a compound capable of labeling the malarial protein VAR2CSA. The chimeric antigen receptor can identify the VAR2CSA protein or the recombinant protein (rVAR2) of any one of, or at least two of, the domains of the VAR2CSA protein which can bind to placental-like chondroitin sulfate A (pl-CSA). The VAR2CSA protein or rVAS2 protein is capable of targeting several different types of tumor cells by means of binding to the pl-CSA on the surface of the tumor cell.

Abstract: A fuel cell catalyst for oxygen reduction reactions including Pt—Ni—Cu nanoparticles supported on nitrogen-doped mesoporous carbon (MPC) having enhanced activity and durability, and method of making said catalyst. The catalyst is synthesized by employing a solid state chemistry method, which involves thermally pretreating a N-doped MPC to remove moisture from the surface; impregnation of metal precursors on the N-doped MPC under vacuum condition; and reducing the metal precurors in a stream of CO and H2 gas mixture.